| Name | Title | Contact Details |
|---|---|---|
Renee Connolly |
Chief Belonging & Inclusion Officer and SVP of Life Science Communications & Branding | Profile |
Yesim Dogan |
Head of Rewards, Talent Attraction and Development, People Analytics and HR Functions Electronics | Profile |
Kate Hebenstreit |
Talent Advisor | Profile |
Hongjun Zhou |
Director of R&D Digitalization Strategy and Innovation | Profile |
Hongjun Zhou |
Global Head of Research and Development | Profile |
Ergosuture - wound closure, enhanced suturing devices
Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer`s disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer`s disease and expects to start pivotal studies in 2022. The company`s technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT.
Inogent is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nycomed US Inc is a Florham Park, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Jeiven Pharmaceutical Consulting is a Scotch Plains, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.